Evoke Pharma Priced, Nasdaq: EVOK
Developing drugs to treat gastrointestinal disorders and diseases.
Industry: Health Care
First Day Return: -2.2%
Industry: Health Care
EVOK
Developing drugs to treat gastrointestinal disorders and diseases.
| IPO Data | |
|---|---|
| IPO File Date | 05/24/2013 |
| Offer Price | $12.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 2.1 |
| Deal Size ($mm) | $25 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 09/24/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $25 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2007 |
| Employees at IPO | 2 |
| Website www.evokepharma.com | |
IPO News for Evoke Pharma
Evoke Pharma (EVOK) Performance
